Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
24 hedge funds and large institutions have $2.99M invested in Histogen Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 9 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
43% more capital invested
Capital invested by funds: $2.08M → $2.99M (+$905K)
4% less funds holding
Funds holding: 25 → 24 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$819K |
| 2 |
State Street
Boston,
Massachusetts
|
+$179K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$155K |
| 4 |
Renaissance Technologies
New York
|
+$96.2K |
| 5 |
N
Natixis
Paris,
France
|
+$92.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$208K |
| 2 |
BlackRock
New York
|
-$177K |
| 3 |
Bank of New York Mellon
New York
|
-$55K |
| 4 |
NDSI
Newman Dignan & Sheerar Inc
Providence,
Rhode Island
|
-$42K |
| 5 |
CAG
Curtis Advisory Group
Santa Barbara,
California
|
-$19K |
HSTO Hedge Fund Activity: Q2 2021 in Review
24 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2021, worth a combined $2.99M — up 43% from $2.08M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of HSTO and 8 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $819K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $208K sold.
- 24 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2021, down from 25 in Q1 2021.
- Funds reported $2.99M of Histogen Inc. Common Stock stock for Q2 2021, up 43% quarter-over-quarter.
- 8 funds opened new Histogen Inc. Common Stock positions in Q2 2021 and 9 closed out, a net change of -1 holder.
- The largest Histogen Inc. Common Stock buyer in Q2 2021 was Vanguard Group, an estimated $819K added.
- The largest Histogen Inc. Common Stock seller in Q2 2021 was Acadian Asset Management, an estimated $208K sold.
Based on aggregated 13F filings for Q2 2021.